Pharmacokinetics of nano- and microcrystal formulations of low solubility compounds after intramuscular injection to mice
This study highlights that general expectations based on in vitro dissolution (i.e. that smaller particles dissolve faster than larger particles when surrounded by liquid) do not always translate to in vivo and demonstrates the importance of understanding the physicochemical properties of the drug, the characteristics of the formulations and the microphysiology at the delivery site.
Authors
- Kalle Sigfridsson (ORCID: https://orcid.org/0000-0002-6260-8797)
- Aixiang Xue
- Krishna Aluri (ORCID: https://orcid.org/0000-0002-7460-8727)
- Diane Ramsden (ORCID: https://orcid.org/0000-0003-2994-0728)
Institutions
- AstraZeneca (South Korea) (KR)
- AstraZeneca (Sweden) (SE)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1093/jpp/rgae118
- Citations
- 1
- Primary Topic
- Intramuscular injections and effects
- Type
- article
- Field-Weighted Citation Impact
- 0.69